SCHEMBL13626697

SCHEMBL13626697

CCN(c1cc(OC)c(OC)cc1[C@@H]1CCc2cc(O)ccc2C1)C(C)c1ccc(OCCN(C)CC2CCOCC2)cc1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.39
ESR2 Q92731 1/20 0.39
DRD2 P14416 7/20 0.32
DRD3 P35462 6/20 0.32
CYP26A1 O43174 1/20 0.31
DRD4 P21917 3/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
HTR1A P08908 1/20 0.31
ADRB2 P07550 1/20 0.31
CYP2D6 P10635 1/20 0.31
CASP1 P29466 1/20 0.31
RAB9A P51151 1/20 0.31
LMNA P02545 2/20 0.31
MAPT P10636 1/20 0.31
OPRM1 P35372 1/20 0.31
OPRK1 P41145 1/20 0.31
CA9 Q16790 1/20 0.31
DRD1 P21728 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13626695 0.91 ESR1 (0.38) ESR1ESR2DRD2DRD3DRD4
SCHEMBL13626666 0.89 ESR1 (0.42) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL13626694 0.89 ESR1 (0.37) ESR1ESR2DRD2DRD3DRD4
SCHEMBL13626690 0.89 ESR1 (0.37) ESR1ESR2DRD2DRD3DRD4
SCHEMBL13626681 0.88 ESR1 (0.40) ESR1ESR2DRD2DRD3DRD4
SCHEMBL13626683 0.88 ESR1 (0.42) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL13626667 0.87 ESR1 (0.42) ESR1ESR2DRD2DRD3DRD4
SCHEMBL229331 0.87 ESR1 (0.54) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL229330 0.87 ESR1 (0.54) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL13626682 0.87 ESR1 (0.40) ESR1ESR2DRD2DRD3CYP26A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612114-B2 Such as (R)-6-{2-{ethyl[4-(2-ethylaminoethyl)benzyl]amino }-4-methoxyphenyl }-5,6,7,8-tetrahydronaphthalen-2-ol; osteoporosis; breast cancer EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-11-03 US disclosed